Alongside its role in repairing therapy-induced DNA lesions, HMGB1 orchestrates a complementary cytoplasmic defense program that contributes to cancer therapy resistance through its capacity to stimulate autophagy under stress. The gene discussed is HMGB1; the disease is cancer.